Skip to main content
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. — Investor Relations & Filings

Ticker · ENVB ISIN · US02362F3029 US Professional, scientific and technical activities
Open in API
Filings indexed 1,028 across all filing types
Latest filing 2021-06-22 Merger & Acquisition
Country US United States of America
Listing US ENVB

About Enveric Biosciences, Inc.

https://www.enveric.com/

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Recent filings

Filing Released Lang Actions
Merger & Acquisition 2021
Merger & Acquisition Classification · 100% confidence The document is a Form S-4 Registration Statement filed with the SEC, which is used for securities registration in connection with mergers and acquisitions. It includes detailed information about an amalgamation (merger) proposal between Enveric Biosciences, Inc. and MagicMed Industries Inc., including the terms of the transaction, stock issuance, and shareholder voting details. The presence of a proxy statement/prospectus related to the merger and solicitation of shareholder votes further confirms this is a merger-related filing. The document is not a simple announcement or a proxy solicitation alone but a comprehensive registration statement for the transaction. Therefore, the appropriate classification is 'Merger & Acquisition' (MA).
2021-06-22 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or updates that shareholders should know about between periodic reports. The text references an attached investor presentation related to a proposed transaction between Enveric Biosciences, Inc. and MagicMed Industries Inc. It explicitly states that the presentation is furnished under Item 7.01 Regulation FD Disclosure and is not considered filed for purposes of Section 18 of the Exchange Act. The document also discusses forthcoming filings including a proxy statement and prospectus related to the transaction, but these are not part of this filing. The primary content is the announcement of the investor presentation and related transaction information, not the presentation itself or a full financial report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories, especially SEC current reports like Form 8-K that announce events or furnish information but do not contain full financial statements or detailed reports.
2021-06-08 English
425 Filing
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The text references an attached investor presentation related to a proposed transaction (merger/acquisition) between Enveric Biosciences, Inc. and MagicMed Industries Inc. It explicitly states that the investor presentation is attached as Exhibit 99.1 and that additional proxy materials will be filed later. The document is not the investor presentation itself but a regulatory filing announcing the event and furnishing the presentation. The content focuses on the transaction and solicitation of proxies, indicating M&A activity. Given the nature of the filing (Form 8-K) and the emphasis on the transaction and solicitation materials, the best classification is M&A Activity (TAR). The document length (9845 characters) supports it being a substantive filing rather than a brief announcement. Therefore, the classification is TAR with high confidence.
2021-06-08 English
Director's Dealing 2021
Director's Dealing
2021-05-28 English
M&A Activity 2021
M&A Activity Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 24, 2021, by Enveric Biosciences, Inc. It reports the entry into a material definitive agreement (an Amalgamation Agreement) to acquire MagicMed Industries Inc. The document details the terms of the merger, share issuance, voting agreements, and appointment of new officers as part of the transaction. The content focuses on merger-related disclosures and management appointments tied to the transaction. This type of filing is a current report on material events, specifically related to merger and acquisition activity. It is not a full annual or quarterly report, nor is it a proxy or voting results announcement. The primary subject is the merger agreement and related corporate actions. Therefore, the appropriate classification is M&A Activity (TAR).
2021-05-24 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 18, 2021, by Enveric Biosciences, Inc. It announces the issuance of a press release regarding financial results for the first fiscal quarter ended March 31, 2021. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release as an exhibit. The length of the document is 3793 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the 'MENU VS MEAL' rule, this is an announcement of a report (the press release) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such filings that do not fit other specific categories and are announcements or certifications rather than full reports.
2021-05-20 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.